Victory Capital Management’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$801K Sell
62,509
-12,658
-17% -$161K ﹤0.01% 1919
2025
Q4
$676K Buy
75,167
+32,718
+77% +$450K ﹤0.01% 1964
2025
Q3
$733K Buy
42,449
+23
+0.1% +$283 ﹤0.01% 1966
2025
Q2
$398K Buy
42,426
+30,634
+260% +$252K ﹤0.01% 2098
2025
Q1
$83.8K Sell
11,792
-590
-5% -$5.96K ﹤0.01% 2327
2024
Q4
$144K Sell
12,382
-272
-2% -$4.25K ﹤0.01% 2288
2024
Q3
$260K Buy
12,654
+429
+4% +$9.89K ﹤0.01% 2162
2024
Q2
$274K Sell
12,225
-174
-1% -$4.14K ﹤0.01% 2123
2024
Q1
$341K Buy
12,399
+567
+5% +$15.7K ﹤0.01% 2083
2023
Q4
$361K Sell
11,832
-15,484
-57% -$445K ﹤0.01% 2080
2023
Q3
$864K Buy
27,316
+470
+2% +$18.2K ﹤0.01% 1731
2023
Q2
$1.09M Sell
26,846
-210
-0.8% -$8.52K ﹤0.01% 1622
2023
Q1
$1.01M Buy
27,056
+1,761
+7% +$69.1K ﹤0.01% 1689
2022
Q4
$883K Sell
25,295
-533
-2% -$25.3K ﹤0.01% 1800
2022
Q3
$1.45M Sell
25,828
-2,437
-9% -$151K ﹤0.01% 1563
2022
Q2
$1.46M Sell
28,265
-559,666
-95% -$28.4M ﹤0.01% 1578
2022
Q1
$42M Sell
587,931
-39,566
-6% -$3.35M 0.04% 594
2021
Q4
$74.2M Sell
627,497
-141,959
-18% -$17.8M 0.07% 394
2021
Q3
$103M Buy
769,456
+375,933
+96% +$56.9M 0.1% 259
2021
Q2
$63.7M Buy
393,523
+353,428
+881% +$27.5M 0.06% 454
2021
Q1
$3.22M Buy
40,095
+4,503
+13% +$302K ﹤0.01% 1496
2020
Q4
$1.94M Sell
35,592
-1,793
-5% -$65.1K ﹤0.01% 1524
2020
Q3
$743K Buy
+37,385
New +$780K ﹤0.01% 1826
2020
Q2
Sell
-10,846
Closed -$132K 3007
2020
Q1
$132K Buy
10,846
+2,332
+27% +$31.4K ﹤0.01% 2449
2019
Q4
$125K Buy
8,514
+3,493
+70% +$48.6K ﹤0.01% 2469
2019
Q3
$67K Buy
+5,021
New +$80.1K ﹤0.01% 2569

Other funds holding NTLA